nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—Cardiac fibrillation—Lisinopril—dilated cardiomyopathy	0.0292	0.0392	CcSEcCtD
Bupivacaine—Hypotensive—Furosemide—dilated cardiomyopathy	0.0279	0.0374	CcSEcCtD
Bupivacaine—SCN4A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0257	0.149	CbGpPWpGaD
Bupivacaine—SCN10A—Interaction between L1 and Ankyrins—SCN5A—dilated cardiomyopathy	0.0248	0.144	CbGpPWpGaD
Bupivacaine—Breast pain—Spironolactone—dilated cardiomyopathy	0.0214	0.0288	CcSEcCtD
Bupivacaine—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0184	0.0247	CcSEcCtD
Bupivacaine—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.0176	0.0237	CcSEcCtD
Bupivacaine—Mepivacaine—SCN5A—dilated cardiomyopathy	0.0176	0.212	CrCbGaD
Bupivacaine—Ranolazine—SCN5A—dilated cardiomyopathy	0.0176	0.212	CrCbGaD
Bupivacaine—Ropivacaine—SCN5A—dilated cardiomyopathy	0.0139	0.167	CrCbGaD
Bupivacaine—Lethargy—Spironolactone—dilated cardiomyopathy	0.0138	0.0186	CcSEcCtD
Bupivacaine—Tocainide—SCN5A—dilated cardiomyopathy	0.0131	0.157	CrCbGaD
Bupivacaine—Laryngeal oedema—Lisinopril—dilated cardiomyopathy	0.0119	0.016	CcSEcCtD
Bupivacaine—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0111	0.0149	CcSEcCtD
Bupivacaine—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0105	0.014	CcSEcCtD
Bupivacaine—Lidocaine—SCN5A—dilated cardiomyopathy	0.0101	0.122	CrCbGaD
Bupivacaine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00996	0.0134	CcSEcCtD
Bupivacaine—SCN4A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00986	0.0573	CbGpPWpGaD
Bupivacaine—SCN10A—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00951	0.0553	CbGpPWpGaD
Bupivacaine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.0091	0.0122	CcSEcCtD
Bupivacaine—Breast pain—Lisinopril—dilated cardiomyopathy	0.00874	0.0117	CcSEcCtD
Bupivacaine—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00845	0.0113	CcSEcCtD
Bupivacaine—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00825	0.0111	CcSEcCtD
Bupivacaine—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.00812	0.0109	CcSEcCtD
Bupivacaine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00785	0.0105	CcSEcCtD
Bupivacaine—Neck pain—Lisinopril—dilated cardiomyopathy	0.00772	0.0104	CcSEcCtD
Bupivacaine—Purpura—Furosemide—dilated cardiomyopathy	0.00766	0.0103	CcSEcCtD
Bupivacaine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.00763	0.0102	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00762	0.0102	CcSEcCtD
Bupivacaine—Lethargy—Furosemide—dilated cardiomyopathy	0.00753	0.0101	CcSEcCtD
Bupivacaine—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00749	0.0101	CcSEcCtD
Bupivacaine—Neuropathy—Lisinopril—dilated cardiomyopathy	0.00716	0.00962	CcSEcCtD
Bupivacaine—Urinary retention—Furosemide—dilated cardiomyopathy	0.00702	0.00942	CcSEcCtD
Bupivacaine—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00691	0.00928	CcSEcCtD
Bupivacaine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00683	0.00916	CcSEcCtD
Bupivacaine—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00679	0.00912	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.00674	0.00905	CcSEcCtD
Bupivacaine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00672	0.00903	CcSEcCtD
Bupivacaine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00667	0.00895	CcSEcCtD
Bupivacaine—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00651	0.00874	CcSEcCtD
Bupivacaine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00642	0.00862	CcSEcCtD
Bupivacaine—Injury—Lisinopril—dilated cardiomyopathy	0.00602	0.00809	CcSEcCtD
Bupivacaine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00593	0.00796	CcSEcCtD
Bupivacaine—Lidocaine—SLC22A5—dilated cardiomyopathy	0.00582	0.07	CrCbGaD
Bupivacaine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00576	0.00773	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00572	0.00768	CcSEcCtD
Bupivacaine—Drowsiness—Furosemide—dilated cardiomyopathy	0.00569	0.00764	CcSEcCtD
Bupivacaine—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00554	0.00744	CcSEcCtD
Bupivacaine—Diplopia—Lisinopril—dilated cardiomyopathy	0.00554	0.00744	CcSEcCtD
Bupivacaine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00549	0.00738	CcSEcCtD
Bupivacaine—Sweating—Furosemide—dilated cardiomyopathy	0.00545	0.00732	CcSEcCtD
Bupivacaine—Urticaria—Spironolactone—dilated cardiomyopathy	0.0053	0.00711	CcSEcCtD
Bupivacaine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00527	0.00708	CcSEcCtD
Bupivacaine—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00527	0.00707	CcSEcCtD
Bupivacaine—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00519	0.00697	CcSEcCtD
Bupivacaine—Lidocaine—EGFR—dilated cardiomyopathy	0.00507	0.0609	CrCbGaD
Bupivacaine—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.00506	0.00679	CcSEcCtD
Bupivacaine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00491	0.0066	CcSEcCtD
Bupivacaine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00476	0.00639	CcSEcCtD
Bupivacaine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00472	0.00633	CcSEcCtD
Bupivacaine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00471	0.00632	CcSEcCtD
Bupivacaine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00466	0.00626	CcSEcCtD
Bupivacaine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00456	0.00613	CcSEcCtD
Bupivacaine—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00456	0.00612	CcSEcCtD
Bupivacaine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00444	0.00597	CcSEcCtD
Bupivacaine—Erythema—Furosemide—dilated cardiomyopathy	0.00444	0.00597	CcSEcCtD
Bupivacaine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00441	0.00592	CcSEcCtD
Bupivacaine—Flatulence—Furosemide—dilated cardiomyopathy	0.00438	0.00588	CcSEcCtD
Bupivacaine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00427	0.00574	CcSEcCtD
Bupivacaine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00424	0.00569	CcSEcCtD
Bupivacaine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00419	0.00562	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00418	0.00562	CcSEcCtD
Bupivacaine—Headache—Spironolactone—dilated cardiomyopathy	0.00418	0.00561	CcSEcCtD
Bupivacaine—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00415	0.00557	CcSEcCtD
Bupivacaine—Anaemia—Furosemide—dilated cardiomyopathy	0.00411	0.00552	CcSEcCtD
Bupivacaine—Sweating—Lisinopril—dilated cardiomyopathy	0.00409	0.00549	CcSEcCtD
Bupivacaine—Agitation—Furosemide—dilated cardiomyopathy	0.00408	0.00548	CcSEcCtD
Bupivacaine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00407	0.00546	CcSEcCtD
Bupivacaine—Nausea—Spironolactone—dilated cardiomyopathy	0.00396	0.00532	CcSEcCtD
Bupivacaine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.0039	0.00524	CcSEcCtD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00378	0.022	CbGpPWpGaD
Bupivacaine—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00377	0.00507	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00376	0.00505	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00373	0.0217	CbGpPWpGaD
Bupivacaine—Confusional state—Furosemide—dilated cardiomyopathy	0.00366	0.00491	CcSEcCtD
Bupivacaine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00363	0.00487	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—SCN5A—dilated cardiomyopathy	0.00359	0.0209	CbGpPWpGaD
Bupivacaine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00357	0.0048	CcSEcCtD
Bupivacaine—Shock—Furosemide—dilated cardiomyopathy	0.00357	0.00479	CcSEcCtD
Bupivacaine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00356	0.00478	CcSEcCtD
Bupivacaine—Flushing—Lisinopril—dilated cardiomyopathy	0.00356	0.00477	CcSEcCtD
Bupivacaine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00352	0.00473	CcSEcCtD
Bupivacaine—SCN4A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00351	0.0204	CbGpPWpGaD
Bupivacaine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00351	0.00471	CcSEcCtD
Bupivacaine—Chills—Lisinopril—dilated cardiomyopathy	0.00344	0.00462	CcSEcCtD
Bupivacaine—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00342	0.0046	CcSEcCtD
Bupivacaine—Hypotension—Furosemide—dilated cardiomyopathy	0.00339	0.00455	CcSEcCtD
Bupivacaine—SCN10A—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00338	0.0197	CbGpPWpGaD
Bupivacaine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00336	0.00451	CcSEcCtD
Bupivacaine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00333	0.00448	CcSEcCtD
Bupivacaine—Erythema—Lisinopril—dilated cardiomyopathy	0.00333	0.00448	CcSEcCtD
Bupivacaine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00329	0.00441	CcSEcCtD
Bupivacaine—Tension—Lisinopril—dilated cardiomyopathy	0.00327	0.00439	CcSEcCtD
Bupivacaine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00326	0.00437	CcSEcCtD
Bupivacaine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00324	0.00435	CcSEcCtD
Bupivacaine—Back pain—Lisinopril—dilated cardiomyopathy	0.00323	0.00433	CcSEcCtD
Bupivacaine—Somnolence—Furosemide—dilated cardiomyopathy	0.00322	0.00433	CcSEcCtD
Bupivacaine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00321	0.0043	CcSEcCtD
Bupivacaine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00315	0.00423	CcSEcCtD
Bupivacaine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00314	0.00422	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00313	0.0042	CcSEcCtD
Bupivacaine—Tremor—Lisinopril—dilated cardiomyopathy	0.00312	0.0042	CcSEcCtD
Bupivacaine—Pain—Furosemide—dilated cardiomyopathy	0.0031	0.00416	CcSEcCtD
Bupivacaine—Constipation—Furosemide—dilated cardiomyopathy	0.0031	0.00416	CcSEcCtD
Bupivacaine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00308	0.00414	CcSEcCtD
Bupivacaine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00305	0.00409	CcSEcCtD
Bupivacaine—Syncope—Lisinopril—dilated cardiomyopathy	0.00299	0.00402	CcSEcCtD
Bupivacaine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00299	0.00401	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00297	0.00398	CcSEcCtD
Bupivacaine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00295	0.00396	CcSEcCtD
Bupivacaine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00293	0.00394	CcSEcCtD
Bupivacaine—Cough—Lisinopril—dilated cardiomyopathy	0.00291	0.00391	CcSEcCtD
Bupivacaine—Urticaria—Furosemide—dilated cardiomyopathy	0.00288	0.00387	CcSEcCtD
Bupivacaine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00287	0.00385	CcSEcCtD
Bupivacaine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00287	0.00385	CcSEcCtD
Bupivacaine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00284	0.00381	CcSEcCtD
Bupivacaine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00283	0.0038	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00282	0.00379	CcSEcCtD
Bupivacaine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00274	0.00368	CcSEcCtD
Bupivacaine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00272	0.00365	CcSEcCtD
Bupivacaine—Oedema—Lisinopril—dilated cardiomyopathy	0.00272	0.00365	CcSEcCtD
Bupivacaine—Infection—Lisinopril—dilated cardiomyopathy	0.0027	0.00363	CcSEcCtD
Bupivacaine—Shock—Lisinopril—dilated cardiomyopathy	0.00268	0.0036	CcSEcCtD
Bupivacaine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00267	0.00359	CcSEcCtD
Bupivacaine—SCN4A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00266	0.0155	CbGpPWpGaD
Bupivacaine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00266	0.00357	CcSEcCtD
Bupivacaine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00264	0.00355	CcSEcCtD
Bupivacaine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00263	0.00353	CcSEcCtD
Bupivacaine—Asthenia—Furosemide—dilated cardiomyopathy	0.0026	0.00349	CcSEcCtD
Bupivacaine—SCN4A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.0026	0.0151	CbGpPWpGaD
Bupivacaine—Pruritus—Furosemide—dilated cardiomyopathy	0.00257	0.00345	CcSEcCtD
Bupivacaine—SCN10A—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00256	0.0149	CbGpPWpGaD
Bupivacaine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00254	0.00341	CcSEcCtD
Bupivacaine—SCN10A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00251	0.0146	CbGpPWpGaD
Bupivacaine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00248	0.00333	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00248	0.00333	CcSEcCtD
Bupivacaine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00246	0.00331	CcSEcCtD
Bupivacaine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00244	0.00328	CcSEcCtD
Bupivacaine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00243	0.00326	CcSEcCtD
Bupivacaine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00242	0.00325	CcSEcCtD
Bupivacaine—Dizziness—Furosemide—dilated cardiomyopathy	0.0024	0.00322	CcSEcCtD
Bupivacaine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.0024	0.00322	CcSEcCtD
Bupivacaine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00237	0.00318	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00235	0.00315	CcSEcCtD
Bupivacaine—Pain—Lisinopril—dilated cardiomyopathy	0.00233	0.00313	CcSEcCtD
Bupivacaine—Constipation—Lisinopril—dilated cardiomyopathy	0.00233	0.00313	CcSEcCtD
Bupivacaine—Vomiting—Furosemide—dilated cardiomyopathy	0.00231	0.0031	CcSEcCtD
Bupivacaine—Headache—Furosemide—dilated cardiomyopathy	0.00227	0.00305	CcSEcCtD
Bupivacaine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00224	0.00301	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00223	0.00299	CcSEcCtD
Bupivacaine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00216	0.0029	CcSEcCtD
Bupivacaine—Nausea—Furosemide—dilated cardiomyopathy	0.00215	0.00289	CcSEcCtD
Bupivacaine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00215	0.00289	CcSEcCtD
Bupivacaine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00215	0.00289	CcSEcCtD
Bupivacaine—SCN4A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00209	0.0121	CbGpPWpGaD
Bupivacaine—SCN10A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00202	0.0117	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00201	0.00269	CcSEcCtD
Bupivacaine—CYP2C19—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00199	0.0116	CbGpPWpGaD
Bupivacaine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00195	0.00262	CcSEcCtD
Bupivacaine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00193	0.00259	CcSEcCtD
Bupivacaine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00186	0.0025	CcSEcCtD
Bupivacaine—CYP2D6—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00183	0.0106	CbGpPWpGaD
Bupivacaine—Dizziness—Lisinopril—dilated cardiomyopathy	0.0018	0.00242	CcSEcCtD
Bupivacaine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00173	0.00232	CcSEcCtD
Bupivacaine—Headache—Lisinopril—dilated cardiomyopathy	0.0017	0.00229	CcSEcCtD
Bupivacaine—Nausea—Lisinopril—dilated cardiomyopathy	0.00162	0.00217	CcSEcCtD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00159	0.00922	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00158	0.00917	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00157	0.00913	CbGpPWpGaD
Bupivacaine—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00155	0.009	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00152	0.0088	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00148	0.00857	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00143	0.0083	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00141	0.0082	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00136	0.0079	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00136	0.0079	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00126	0.00734	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00122	0.00711	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00122	0.00709	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00116	0.00673	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00112	0.00652	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00111	0.00645	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00108	0.00628	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00105	0.00607	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00104	0.00602	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00104	0.00602	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000994	0.00577	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000992	0.00576	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000983	0.00571	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000963	0.00559	CbGpPWpGaD
Bupivacaine—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000951	0.00552	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—ITGB1—dilated cardiomyopathy	0.000948	0.00551	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000932	0.00542	CbGpPWpGaD
Bupivacaine—SCN10A—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000917	0.00533	CbGpPWpGaD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000881	0.00512	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000796	0.00463	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	0.00079	0.00459	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—RAC1—dilated cardiomyopathy	0.000762	0.00443	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000755	0.00439	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000736	0.00427	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000715	0.00415	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000701	0.00408	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00069	0.00401	CbGpPWpGaD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000687	0.00399	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000676	0.00393	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	0.000598	0.00348	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000585	0.0034	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000585	0.0034	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—CD36—dilated cardiomyopathy	0.000577	0.00335	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000564	0.00328	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00056	0.00326	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000545	0.00317	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000544	0.00316	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—RAC1—dilated cardiomyopathy	0.000544	0.00316	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000531	0.00309	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000531	0.00309	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000527	0.00306	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	0.000524	0.00304	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000513	0.00298	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—RAF1—dilated cardiomyopathy	0.000505	0.00294	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000494	0.00287	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000478	0.00278	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000473	0.00275	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00045	0.00261	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000447	0.0026	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000427	0.00248	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000425	0.00247	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000409	0.00237	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000399	0.00232	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000388	0.00225	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	0.000374	0.00217	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—RAF1—dilated cardiomyopathy	0.000361	0.00209	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	0.000359	0.00209	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000354	0.00205	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—EGFR—dilated cardiomyopathy	0.000346	0.00201	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000331	0.00193	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000317	0.00184	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000314	0.00182	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000314	0.00182	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000306	0.00178	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000306	0.00178	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000301	0.00175	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000292	0.0017	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000292	0.00169	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000292	0.00169	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000288	0.00167	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000283	0.00164	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	0.000256	0.00149	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—EGFR—dilated cardiomyopathy	0.000247	0.00144	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	0.000244	0.00142	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	0.000243	0.00141	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000241	0.0014	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TNF—dilated cardiomyopathy	0.000235	0.00137	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000229	0.00133	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	0.000228	0.00133	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000223	0.0013	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.00021	0.00122	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	0.000206	0.0012	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.0002	0.00116	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000197	0.00114	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.00019	0.0011	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000189	0.0011	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000178	0.00103	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000178	0.00103	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AGT—dilated cardiomyopathy	0.00017	0.000987	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000161	0.000935	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000146	0.000848	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000137	0.000798	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000137	0.000795	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	0.000126	0.000732	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000124	0.000721	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	0.000123	0.000713	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000118	0.000685	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	0.00011	0.000642	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.81e-05	0.00057	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.56e-05	0.000555	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.6e-05	0.0005	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EGFR—dilated cardiomyopathy	8.08e-05	0.00047	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	5.61e-05	0.000326	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	5.46e-05	0.000317	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	5.16e-05	0.0003	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	5.02e-05	0.000292	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	4.92e-05	0.000286	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	4.52e-05	0.000263	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	4.37e-05	0.000254	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	4.26e-05	0.000247	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.83e-05	0.000223	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	3.37e-05	0.000196	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	3.28e-05	0.000191	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.96e-05	0.000172	CbGpPWpGaD
